Systemic therapy a risk factor for glaucoma development and progression

Systemic therapy a risk factor for glaucoma development and progression

<p> <b>A.M. Getmanova<sup>1</sup>, A.Yu. Brezhnev<sup>2</sup>, A.V. Kuroyedov<sup>3,4</sup>, V.I. Baranov<sup>2</sup>, A.S. Dvornikov<sup>4</sup></b> </p> <p> <b><sup>1</sup>Bryansk Regional...

Full description

Bibliographic Details
Main Authors:	A.M. Getmanova, A.Yu. Brezhnev, A.V. Kuroyedov, V.I. Baranov, A.S. Dvornikov
Format:	Article
Language:	Russian
Published:	Prime-Media 2020-11-01
Series:	РМЖ "Клиническая офтальмология"
Online Access:	http://clinopht.com/upload/iblock/ac5/ac54f18f94b53696008f903eda3f2c1d.pdf

Similar Items

Systemic hypotension and low perfusion pressure as risk factors for primary open-angle glaucoma progression
by: O.S. Myakonkaya, et al.
Published: (2023-11-01)

Association between instillation time of glaucoma eye drops and their efficacy
by: A.M. Getmanova, et al.
Published: (2020-06-01)

Effect of intravitreal injections on the progression and prognosis of primary open-angle glaucoma
by: A.B. Movsisyan, et al.
Published: (2021-12-01)

Ophthalmic risk factors for primary open angle glaucoma
by: V.P. Erichev, et al.
Published: (2019-07-01)

Experimental Models of Glaucoma
by: O. N. Onufriichuk, et al.
Published: (2022-01-01)

Risk factors affecting progression and course of primary open-angle glaucoma in patients with different disease stages (multicenter study)
by: N.E. Fomin, et al.
Published: (2022-05-01)

Gender differences in glaucoma
by: S. A. Zubasheva, et al.
Published: (2021-09-01)

Systemic risk factors for developing of primary open-angle glaucoma
by: E.A. Egorov, et al.
Published: (2018-09-01)

Glaucoma progression during the COVID-19 pandemics
by: V.E. Korelina, et al.
Published: (2021-09-01)

Making a diagnosis of glaucoma at the present time
by: A.B. Movsisyan, et al.
Published: (2023-03-01)

Diagnostics of glaucoma before clinical manifestations
by: N.E. Fomin, et al.
Published: (2020-08-01)

Markers of vascular autoregulation in primary open-angle glaucoma
by: N.E. Fomin, et al.
Published: (2019-11-01)

Diagnosing glaucoma in optometry practice
by: A.V. Korneeva, et al.
Published: (2022-11-01)

Choice regularities of antihypertensive therapy regimens of primary open-angle glaucoma in conditions of real clinical practice
by: Z.M. Nagornova, et al.
Published: (2018-09-01)

Thyroid disorders and their role in the pathogenesis of glaucoma
by: T. V. Chernyakova, et al.
Published: (2022-12-01)

Comparative analysis of the efficacy and safety of fixed-dose combinations versus their individual components for open-angle glaucoma
by: Z.M. Nagornova, et al.
Published: (2019-04-01)

State-of-the-art of loading and unloading tests for glaucoma: potentialities and informative value
by: O.S. Myakonkaya, et al.
Published: (2021-09-01)

The new factors defining variability of circadian’s rhythms of intraocular and perfusion pressure of glaucoma patients
by: N. A. Baranova, et al.
Published: (2016-04-01)

ADDITIVE AND COMBINED GLAUCOMA THERAPY: PRINCIPLES AND PRACTICE
by: A. V. Kuroyedov, et al.
Published: (2018-10-01)

State of the art of glaucoma diagnosis: neural networks and artificial intelligence
by: A.V. Kuroyedov, et al.
Published: (2019-11-01)

IOP-lowering effect and tolerability of prostaglandin analogues in primary open-angle glaucoma and ocular hypertension as risk factors for glaucoma progression
by: A.V. Belogurova, et al.
Published: (2019-04-01)

GLAUCOMA PROGRESSION. IMPACT OF RISK FACTORS ON THE DISEASE
by: A. Zh. Fursova, et al.
Published: (2020-03-01)

Drainage surgery for primary open-angle glaucoma: past, present, future
by: A. S. Basinsky, et al.
Published: (2021-07-01)

International Multicenter Glaucoma Research
by: S. Yu. Petrov, et al.
Published: (2018-10-01)

Epidemiological analysis primary open-angle glaucoma incidence and prevalence in Russia
by: A.B. Movsisyan, et al.
Published: (2022-02-01)

Prerequisites to Use Preservative-Free Drugs in Medication Therapy of Glaucoma
by: D. A. Dorofeev, et al.
Published: (2021-10-01)

Glaucoma "landscape" in Russia, CIS and Eastern European countries: what has changed over 15 years?
by: A.Yu. Brezhnev, et al.
Published: (2023-06-01)

Suspected glaucoma and early stage glaucoma: differential diagnostic criteria
by: R. V. Avdeev, et al.
Published: (2018-10-01)

PECULIARITIES OF RISK FACTORS FOR GLAUCOMA PROGRESSION AND THEIR IMPACT ON DEVELOPMENT OF THE DISEASE
by: O. B. Koshchynets, et al.
Published: (2019-10-01)

Refractory glaucoma laser treatment: together or instead?
by: A. P. Shakhalova, et al.
Published: (2021-12-01)

Preperimetric glaucoma
by: N. A. Bakunina, et al.
Published: (2021-03-01)

Influence of Personal Respiratory and Visual Protective Equipment on the Development and Progression of Dry Eye Syndrome
by: A. V. Kuroyedov, et al.
Published: (2020-09-01)

Speed of development and speed of progression of primary open-angle glaucoma
by: S.O. Rykov, et al.
Published: (2018-10-01)

The psychology of a glaucoma patient
by: L. M. Gabdrakhmanov, et al.
Published: (2020-09-01)

Loss of Corneal Endothelial Cells during Glaucoma Surgery
by: I. V. Shaposhnikova, et al.
Published: (2020-12-01)

Secondary aphakic glaucoma in children: a 15-year retrospective study
by: N.N. Sadovnikova, et al.
Published: (2023-06-01)

Violation of the vascular platelet hemostasis as a risk factor of primary open-angle glaucoma progression
by: N. I. Kurysheva, et al.
Published: (2015-10-01)

Impact of glaucoma and glaucoma surgery on quality of life
by: V.P. Erichev, et al.
Published: (2022-02-01)

IOP-lowering therapy and ocular surface in glaucoma. Part 1. The effects of drug substances of glaucoma medications on the ocular surface
by: A.V. Antonova, et al.
Published: (2020-06-01)

Characteristics of glaucoma therapy with prostaglandin analogues nowadays
by: I.B. Alekseev, et al.
Published: (2022-09-01)